The American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) is hosting its 2018 Annual Meeting October 10-13 in Washington, DC, with a core focus on the implementation of precision medicine. The association, founded in 1953, includes more than 4500 members comprised primarily of neurologists and physical medicine and rehabilitation specialists serving patients who have a variety of nerve and muscle diseases.
This year’s AANEM Annual Meeting includes 4 days of scientific programming, including multiple plenary sessions, abstract poster presentations, and an exhibit hall. CME credit is available for nearly all sessions and workshops.
“The highlights of the meeting are always the plenary session, which this year will focus on the advances in treatment for rare previously untreatable conditions and how we struggle to get (and pay for) these novel treatments for these orphan diseases,” AANEM president Eric J. Sorenson, MD, told Neurology Advisor. “Other highlights are the educational opportunities for practitioners to improve their diagnostic procedural skills and enhance their knowledge of neuromuscular and musculoskeletal diseases.”
A total of 6 plenary presentations are scheduled to take place throughout the meeting, highlighting both clinical research and ethical concerns that affect clinical practice.
1. Orphan Drug Pricing – A View From the Trenches
- Presented by A. Gordon Smith, MD
2. RNA-Targeted Mechanism and Therapeutics for ALS
- Presented by Timothy M. Miller, MD, PhD
3. ALS and Related NM Diseases in the Precision Medicine Era
- Presented by Matthew B. Harms, MD
4. FDA Regulation of Cell Therapy
- Presented by Wilson W. Bryan, MD
5. From Assessing Evidence to Determining a “Fair” Price: How Should the Value of New Treatments for Neuromuscular Disorders Be Evaluated?
- Presented by Steven D. Pearson, MD, MSc, FRCP
6. Precision Medicine Therapeutics in Duchenne Muscular Dystrophy: Dystrophin Restoration and Exercise Mimetics
- Presented by Craig M. McDonald, MD
The 2018 Annual Meeting will also include 13 never-before-offered workshops that will allow attendees to experience hands-on learning from leading faculty. Workshop topics include: Chemodenervation Guidance Techniques: EMG, Nerve Stimulation, and Ultrasound; Neuromuscular Ultrasound: Basic Upper and Lower Extremity; and Sonographic Needle Guidance for Carpal Tunnel Injections, among others.
Lastly, it wouldn’t be a complete Annual Meeting without opportunities to network and socialize. The 2018 AANEM Annual Meeting includes several notable events at which attendees can connect with peers in a more relaxed atmosphere, including the Speed Networking event; President’s Reception; Abstract Award Reception; and EMG Tonight, an entertaining and interactive event that mimics the format of The Tonight Show.
“I hope each attendee leaves the conference with a better understanding of the complexities of drug development and the process of drug approval,” Dr Sorenson said. “I hope they gain a perspective of the implications of this process to patients and to patients’ hopes and expectations. By doing so, I think all the providers in attendance will gain empathy for their patients and the predicaments they face as they individually struggle with the disease and financial burdens they often find themselves in.”
To view abstracts being presented at the meeting, click here.
On-site registration is available throughout the duration of the meeting.